Immunohistochemical detection of the ras oncogene product p21 in advanced ovarian cancer. Lack of correlation with clinical outcome.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Archives of Pathology & Laboratory Medicine

• Publication date

  1988-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 3276289
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The value of tumour marker CA 125 in surgical pathology

  1987cited by this paper
• Tumor ploidy as a major prognostic factor in advanced ovarian cancer

  1987cited by this paper
• Expression of ras oncogene p21 in prostate cancer.

  1986cited by this paper
• Immunohistochemical detection of ras oncogene p21 product in benign and malignant mammary tissue in man.

  1986cited by this paper
• Elevated ras oncogene expression correlates with lymph node metastases in breast cancer patients.

  1986cited by this paper
• Immunocytochemical demonstration of p21 ras family oncogene product in normal mucosa and in premalignant and malignant tumours of the colorectum.

  1985cited by this paper
• ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma

  1985cited by this paper
• Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms.

  1985cited by this paper
• Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases

  1984cited by this paper
• Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma.

  1984cited by this paper
• Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas.

  1984cited by this paper
• Expression of cellular oncogenes in human malignancies.

  1984cited by this paper
• Cellular oncogenes and multistep carcinogenesis.

  1983cited by this paper
• Importance of Histologic Grading in the Prognosis of Epithelial Ovarian Carcinoma

  1982cited by this paper

• University of Groningen Ovarian cancer gene therapy

  2017influential citation
• Ras-superfamily GTP-ases in ovarian cancer.

  2009cites this paper
• Clinical significance of p21(WAF1/CIP1) and p53 expression in serous cystadenocarcinoma of the ovary.

  2005cites this paper
• Involvement of the ras genes in female genital tract cancer.

  2005cites this paper
• c-myc Oncogene product P62C-rYc in ovarian mucinous neoplasms: immunohistochemical study correlated with malignancy

  2005cites this paper
• Ovarian cancer gene therapy strategies

  2005cites this paper
• p21 expression predicts outcome in p53-null ovarian carcinoma.

  2003cites this paper
• Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.

  2001cites this paper
• ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum.

  2000cites this paper
• Value of glutathione S-transferase pi and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas.

  1998cites this paper
• p53, c-erbB-2 and p21ras expression in tumor effusion cells of patients with histopathologically different ovarian neoplasms.

  1997cites this paper
• Ovarian cancer: natural history and metastatic pattern.

  1997cites this paper
• Role of p53, Ras p21 and HPV Type 16, 18 on Malignant Transformaton in Inverted Papilloma of Nose and Paranasal Sinus

  1997cites this paper
• Prognostic significance of ras/p21 alterations in human ovarian cancer.

  1997cites this paper
• Oncogenes in gynecologic oncology.

  1996cites this paper
• Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitotic count and Ki-67 are indicators of poor prognosis.

  1996cites this paper
• Ovarian intraepithelial neoplasia and ovarian cancer.

  1996cites this paper
• Oncogenes in Gynecologic Oncology

  1996cites this paper
• Heterogeneity in malignant soft tissue tumors.

  1995cites this paper
• An evaluation of prognostic factors in advanced ovarian cancer.

  1995cites this paper
• Concurrent abnormal expression of erbB-2, myc and ras genes is associated with poor outcome of ovarian cancer patients.

  1995cites this paper
• Errata

  1995cites this paper
• Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues: correlation with histopathological features and epidermal growth factor receptors.

  1994cites this paper
• Molecular biology and genetics of epithelial ovarian cancer.

  1994cites this paper
• Identification of a higher molecular weight protein that shows apparent cross-reactivity with anti-p21ras monoclonal antibodies on western blots.

  1994cites this paper
• Hereditary and familial ovarian cancer.

  1994cites this paper
• Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma.

  1994cites this paper
• Hereditary and Familial Ovarian Cancer

  1994cites this paper
• The proto‐oncogene c‐fms is overexpressed in endometrial cancer

  1994cites this paper
• Expression of ras oncogene p21 protein in normal and neoplastic ovarian tissues: Correlation with histopathologic features and receptors for estrogen, progesterone, and epidermal growth factor

  1993cites this paper
• Molecular and biological factors in the pathogenesis of ovarian cancer.

  1993cites this paper
• Expression of ras p21 oncoprotein in normal and neoplastic human endometrium.

  1993cites this paper
• Flow cytometric analysis of DNA content and RAS P21 oncoprotein expression in ovarian neoplasms.

  1992cites this paper
• Immunolocalization of c-myc oncoprotein in mucinous and serous adenocarcinomas of the ovary.

  1992cites this paper
• Oncogenes in gynecological tumors.

  1992cites this paper
• The genetics of ovarian cancer.

  1992cites this paper
• Prognostic significance of the expression of ras oncogene product in non‐small cell lung cancer

  1992cites this paper
• Oncogenes in ovarian cancer.

  1992cites this paper
• Ras p21 in breast tissue: associations with pathology and cellular localisation.

  1992cites this paper
• Epidemiology and etiology of ovarian cancer.

  1991cites this paper
• Clonogenic growth in vitro: an independent biologic prognostic factor in ovarian carcinoma.

  1991cites this paper
• Ovarian cancer biology.

  1991cites this paper
• Histochemical examination of expression of ras p21 protein and R 1881-binding protein in human prostatic cancers.

  1990cites this paper
• Protooncogene amplification and tumor ploidy in human ovarian neoplasms.

  1990cites this paper
• Diagnostic and prognostic applications of oncogenes in surgical pathology.

  1990cites this paper
• Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissues.

  1990cites this paper
• Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.

  1989cites this paper
• Detection of the ras p21 gene product in human leukemias by flow cytometry

  1989cites this paper
• Amplification of c‐ras‐ki oncogene in human ovarian tumours

  1989cites this paper
• Immunohistochemical Analysis of Human Lung Cancers with Anti-ras p21 Monoclonal Antibodies

  1987cites this paper
• Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression.

  1987cites this paper